Depression is a leading cause of disability worldwide, but an erstwhile party drug is projected to flip the narrative and improve the lives of those in desperate need. Over the last several years, ketamine has emerged as a vanquisher of depression — especially forms impervious to conventional treatment, known as treatment-resistant depression — by rewiring the brain, encouraging a phenomenon known as neuroplasticity.
